Skip to main content

Advertisement

Log in

A Recent Evaluation of Empirical Cephalosporin Treatment and Antibiotic Resistance of Changing Bacterial Profiles in Spontaneous Bacterial Peritonitis

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

An Erratum to this article was published on 17 June 2009

An Erratum to this article was published on 17 June 2009

An Erratum to this article was published on 17 June 2009

An Erratum to this article was published on 17 June 2009

Abstract

The aim of this research is to evaluate the recent changes in microorganisms causing spontaneous bacterial peritonitis in cirrhotic patients, antibiotic resistance, and response to empirical cephalosporin therapy. A total of 218 patients with ascites secondary to cirrhosis were enrolled. Parenteral cefotaxime or cefepime was given to patients who had a neutrophil count of 250/mm3 or more or a positive bacterial culture of ascitic fluid. Antibiotic failure was defined by an absence of clinical improvement and an insufficient decrease in neutrophil count of ascites (<25% of initial value) by the third day of therapy. Of all the patients, 44.6% had culture-negative neutrocytic ascites, 24.8% had spontaneous bacterial peritonitis, and 10.1% had monomicrobial nonneutrocytic bacterascites. Growth in culture was observed in 76 patients (34.9%). The two most common isolated bacteria were Escherichia coli (33.8%) and coagulase-negative Staphylococcus (CoNS; 19.7%). The two cephalosporins were effective against E. coli (82%) and but not against CoNS (44%), while levofloxacin showed reasonable activity against both E. coli (71%) and CoNS (90%) in vitro. We confirmed a recent increased incidence of spontaneous bacterial peritonitis caused by Gram-positive bacteria. Levofloxacin seems to be a good alternative treatment for patients with uncomplicated spontaneous ascites infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Runyon BA, Umland ET, Merlin T. Inoculation of blood culture bottles with ascitic fluid. Improved detection of spontaneous bacterial peritonitis. Arch Intern Med. 1987;147:73–75. doi:10.1001/archinte.147.1.73.

    Article  CAS  PubMed  Google Scholar 

  2. Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology. 1988;95:1351–1355.

    CAS  PubMed  Google Scholar 

  3. Hoefs JC. Spontaneous bacterial peritonitis: prevention and therapy. Hepatology. 1990;12:776–781. doi:10.1002/hep.1840120424.

    Article  CAS  PubMed  Google Scholar 

  4. Runyon BA. Spontaneous bacterial peritonitis: an explosion of information. Hepatology. 1988;8:171–175. doi:10.1002/hep.1840080131.

    Article  CAS  PubMed  Google Scholar 

  5. Cholongitas E, Papatheodoridis GV, Lahanas A. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int. 2005;25:57–61. doi:10.1111/j.1478-3231.2004.0985.x.

    Article  PubMed  Google Scholar 

  6. Dupeyron C, Campillo B, Mangeney N, Richardet JP, Leluan G. Changes in nature and antibiotic resistance of bacteria causing peritonitis in cirrhotic patients over a 20-year period. J Clin Pathol. 1998;51:614–616. doi:10.1136/jcp.51.8.614.

    Article  CAS  PubMed  Google Scholar 

  7. Park YH, Lee HC, Song HG. Recent increase in antibiotic-resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea. J Gastroenterol Hepatol. 2003;18:927–933. doi:10.1046/j.1440-1746.2003.03086.x.

    Article  PubMed  Google Scholar 

  8. Navasa M, Follo A, Llovet JM, et al. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology. 1996;111:1011–1017. doi:10.1016/S0016-5085(96)70069-0.

    Article  CAS  PubMed  Google Scholar 

  9. Terg R, Cobas S, Fassio E, Landeria G. Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. J Hepatol. 2000;33:564–569. doi:10.1034/j.1600-0641.2000.033004564.x.

    Article  CAS  PubMed  Google Scholar 

  10. Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology. 1985;5:457–462. doi:10.1002/hep.1840050319.

    Article  CAS  PubMed  Google Scholar 

  11. Rimola A, Toledo C, Arroyo V, et al. Spontaneous bacterial peritonitis in cirrhosis: therapeutic efficacy of cefotaxime and predictive factors of treatment failure and death. Hepatology. 1990;12:992–997.

    Google Scholar 

  12. Runyon BA, McHutchison JG, Antillon MR, Akriviadis EA, Montano AA. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology. 1991;100:1737–1742.

    CAS  PubMed  Google Scholar 

  13. Akriviadis EA, Runyon BA. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology. 1990;98:127–133.

    CAS  PubMed  Google Scholar 

  14. Kaymakoglu S, Eraksoy H, Okten A, et al. Spontaneous ascitic infection in different cirrhotic groups: prevalence, risk factors and the efficacy of cefotaxime therapy. Eur J Gastroenterol Hepatol. 1997;9:71–76.

    CAS  PubMed  Google Scholar 

  15. Chu CM, Chang KY, Liaw YF. Prevalence and prognostic significance of bacterascites in cirrhosis with ascites. Dig Dis Sci. 1995;40:561–565. doi:10.1007/BF02064369.

    Article  CAS  PubMed  Google Scholar 

  16. Evans LT, Kim WR, Poterucha JJ, Kamath PS. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology. 2003;37:897–901. doi:10.1053/jhep.2003.50119.

    Article  PubMed  Google Scholar 

  17. Runyon BA. Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. Hepatology. 1990;12:710–715. doi:10.1002/hep.1840120415.

    Article  CAS  PubMed  Google Scholar 

  18. Khalif IL, Quigley EM, Konovitch EA, Maximova ID. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis. 2005;37:838–849. doi:10.1016/j.dld.2005.06.008.

    Article  CAS  PubMed  Google Scholar 

  19. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. Crit Care Med. 1999;27:887–892. doi:10.1097/00003246-199905000-00020.

    Article  CAS  PubMed  Google Scholar 

  20. Gaynes RP, Edwards JR, Jarvis WR, et al. Nosocomial infections among high-risk nurseries in the United States. Pediatrics. 1996;98:357–361.

    CAS  PubMed  Google Scholar 

  21. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24:584–602.

    CAS  PubMed  Google Scholar 

  22. Chambers HF. Methicillin-resistant staphylococci. Clin Microbiol Rev. 1988;1:173–186.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mustafa Güçlü.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s10620-009-0868-3

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yakar, T., Güçlü, M., Serin, E. et al. A Recent Evaluation of Empirical Cephalosporin Treatment and Antibiotic Resistance of Changing Bacterial Profiles in Spontaneous Bacterial Peritonitis. Dig Dis Sci 55, 1149–1154 (2010). https://doi.org/10.1007/s10620-009-0825-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-009-0825-1

Keywords

Navigation